NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

由於促血紅細胞生長素 (EPO)的全球市場分析 (2020年∼2030年):新型冠狀病毒感染疾病 (COVID-19) 的成長與變化

Erythropoietin (EPO) Global Market Report 2020-30: COVID-19 Growth and Change

出版商 The Business Research Company 商品編碼 977386
出版日期 按訂單生產 內容資訊 英文 200 Pages
商品交期: 2-10個工作天內
價格
由於促血紅細胞生長素 (EPO)的全球市場分析 (2020年∼2030年):新型冠狀病毒感染疾病 (COVID-19) 的成長與變化 Erythropoietin (EPO) Global Market Report 2020-30: COVID-19 Growth and Change
出版日期: 按訂單生產內容資訊: 英文 200 Pages
簡介

本報告提供全球促血紅細胞生長素 (EPO)的市場結構、趨勢相關分析,市場的主要特徵、結構,及整體市場規模、成長率趨勢預測 (2015∼2019年,2023年,2025年,2030年),各市場區隔 (各產品、各用途) 及各地區、主要國家詳細趨勢,主要企業的簡介,近幾年的主要趨勢,今後的市場機會等調查。

目錄

第1章 摘要整理

第2章 促血紅細胞生長素 (EPO) 市場特徵

第3章 促血紅細胞生長素 (EPO) 市場:市場規模、成長率

  • 市場規模 (以金額為準,2015年∼2019年)
  • 市場規模 (以金額為準,2019年∼2023年,2025年,2030年)
    • 推動市場要素
    • 阻礙市場要素

第4章 促血紅細胞生長素 (EPO) 市場:各領域分析

  • 各產品的市場規模 (以金額為準,成果值、預測值)
    • 紅血球生成素Alpha
    • 紅血球生成素β
    • Darbepoetin-alfa
    • 其他
  • 各用途的市場規模 (以金額為準,成果值、預測值)
    • 癌症
    • 血液疾病
    • 腎臟疾病
    • 神經症
    • 其他

第5章 促血紅細胞生長素 (EPO) 市場:各地區、各國分析

  • 各地區的市場規模 (以金額為準,成果值、預測值)
  • 各國市場規模 (以金額為準,成果值、預測值)

第6章 亞太地區的促血紅細胞生長素 (EPO) 市場

  • 市場概要
  • 各種類的市場規模 (以金額為準,成果值、預測值)
  • 各用途的市場規模 (以金額為準,成果值、預測值)

第7章 中國市場

第8章 印度市場

第9章 日本市場

第10章 澳洲市場

第11章 印尼市場

第12章 韓國市場

第13章 西歐的促血紅細胞生長素 (EPO) 市場

第14章 英國市場

第15章 德國市場

第16章 法國市場

第17章 東歐的促血紅細胞生長素 (EPO) 市場

第18章 俄羅斯市場

第19章 北美的促血紅細胞生長素 (EPO) 市場

第20章 美國市場

第21章 南美的促血紅細胞生長素 (EPO) 市場

第22章 巴西市場

第23章 中東的促血紅細胞生長素 (EPO) 市場

第24章 非洲的促血紅細胞生長素 (EPO) 市場

第25章 促血紅細胞生長素 (EPO) 市場:競爭環境和企業簡介

  • 競爭環境
  • 企業簡介
    • Amgen Inc.
    • Johnson & Johnson
    • Roche Group
    • Pfizer Inc.
    • Novartis

第26章 促血紅細胞生長素 (EPO) 市場上主要企業合併、收購 (M&A)

第27章 促血紅細胞生長素 (EPO) 市場趨勢與策略

第28章 促血紅細胞生長素 (EPO) 市場:未來展望與潛在力分析

第29章 附錄

目錄

“Erythropoietin (EPO) Global Market Report 2020-30: COVID-19 Growth and Change ”from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global erythropoietin (epo) market.

This report focuses on erythropoietin (epo) market which is experiencing strong growth. The report gives a guide to the erythropoietin (epo) market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the erythropoietin (epo)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Erythropoietin (EPO) market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider erythropoietin (epo) market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The erythropoietin (epo) market section of the report gives context. It compares the erythropoietin (epo) market with other segments of the erythropoietin (epo) market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, erythropoietin (epo) indicators comparison.

Scope

Markets Covered:

  • 1) By Product: Epoetin-alfa; Epoetin-beta; Darbepoetin-alfa; Others 2) By Application: Cancer; Hematology; Renal diseases; Neurology; Others
  • Companies Mentioned: Amgen Inc.; Johnson & Johnson; Roche Group; Pfizer Inc.; Novartis
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series:: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations:: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Erythropoietin (EPO) Market Characteristics

3. Erythropoietin (EPO) Market Size And Growth

  • 3.1. Global Erythropoietin (EPO) Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Erythropoietin (EPO) Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Erythropoietin (EPO) Market Segmentation

  • 4.1. Global Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Epoetin-alfa
  • Epoetin-beta
  • Darbepoetin-alfa
  • Others
  • 4.2. Global Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Cancer
  • Hematology
  • Renal diseases
  • Neurology
  • Others

5. Erythropoietin (EPO) Market Regional And Country Analysis

  • 5.1. Global Erythropoietin (EPO) Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Erythropoietin (EPO) Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Erythropoietin (EPO) Market

  • 6.1. Asia-Pacific Erythropoietin (EPO) Market Overview
  • 6.2. Asia-Pacific Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Erythropoietin (EPO) Market

  • 7.1. China Erythropoietin (EPO) Market Overview
  • 7.2. China Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Erythropoietin (EPO) Market

  • 8.1. India Erythropoietin (EPO) Market Overview
  • 8.2. India Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Erythropoietin (EPO) Market

  • 9.1. Japan Erythropoietin (EPO) Market Overview
  • 9.2. Japan Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Erythropoietin (EPO) Market

  • 10.1. Australia Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Erythropoietin (EPO) Market

  • 11.1. Indonesia Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Erythropoietin (EPO) Market

  • 12.1. South Korea Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Erythropoietin (EPO) Market

  • 13.1. Western Europe Erythropoietin (EPO) Market Overview
  • 13.2. Western Europe Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Erythropoietin (EPO) Market

  • 14.1. UK Erythropoietin (EPO) Market Overview
  • 14.2. UK Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Erythropoietin (EPO) Market

  • 15.1. Germany Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Erythropoietin (EPO) Market

  • 16.4. France Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Erythropoietin (EPO) Market

  • 17.1. Eastern Europe Erythropoietin (EPO) Market Overview
  • 17.2. Eastern Europe Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Erythropoietin (EPO) Market

  • 18.1. Russia Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Erythropoietin (EPO) Market

  • 19.1. North America Erythropoietin (EPO) Market Overview
  • 19.2. North America Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Erythropoietin (EPO) Market

  • 20.1. USA Erythropoietin (EPO) Market Overview
  • 20.2. USA Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Erythropoietin (EPO) Market

  • 21.1. South America Erythropoietin (EPO) Market Overview
  • 21.2. South America Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Erythropoietin (EPO) Market

  • 22.1. Brazil Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Erythropoietin (EPO) Market

  • 23.1. Middle East Erythropoietin (EPO) Market Overview
  • 23.2. Middle East Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Erythropoietin (EPO) Market

  • 24.1. Africa Erythropoietin (EPO) Market Overview
  • 24.2. Africa Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Erythropoietin (EPO) Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Erythropoietin (EPO) Market Competitive Landscape And Company Profiles

  • 25.1. Erythropoietin (EPO) Market Competitive Landscape
  • 25.2. Erythropoietin (EPO) Market Company Profiles
    • 25.2.1. Amgen Inc.
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Johnson & Johnson
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Roche Group
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Pfizer Inc.
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Novartis
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Erythropoietin (EPO) Market

27. Erythropoietin (EPO) Market Trends And Strategies

28. Erythropoietin (EPO) Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer